Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03725748
Other study ID # assistant professor2
Secondary ID
Status Not yet recruiting
Phase Phase 2
First received
Last updated
Start date November 1, 2018
Est. completion date June 2019

Study information

Verified date October 2018
Source Kasr El Aini Hospital
Contact hany saad, assistant prof
Phone 01001817211
Email dr_hanysaad@yahoo.co.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a prospective randomized controlled study to the difference between using normal saline or betadine irrigation of wound prior to skin closure in reducing the incidence of wound infection after Cesarean section.


Description:

This study will be conducted at the Department of Obstetrics & Gynecology, Kasr El-Ainy Teaching Hospital, Faculty of Medicine, Cairo University, from February to July 2018.

We include in our study 3oo pregnant women who will undergo Cesarean section. All participants will be divided into 3 groups with a 1:1:1 ratio with 100 patients in each group. Each participant will provide an informed written consent.

Consenting patients will be pre-operatively randomised using numerically ordered cards in sealed envelopes to either the group 1 (wound irrigation with 100 ml of normal saline before skin closure) or the group 2 (wound irrigation with 50 ml of 10% aqueous povidone iodine solution ̋ Betadinȅ ) or the control group (no wound irrigation with normal saline nor betadine).Subjects candidate for the study will be 37 weeks' gestation and require a cesarean section (elective or emergency). Patients with allergy to iodine, history of immunosuppressive drug use, gestationaldiabetes mellitus or preeclampsia, anemic patients, ruptured of membranes and feverish patients will be excluded from the study.

The primary outcome will be the incidence of wound infection. Wound infection is diagnosed when the wound drained purulent material or serosanguineous fluid in association with induration, warmth and tenderness. Suspected wound infections are opened for confirmation and wound cultures will be taken. Haematoma, seroma, or wound breakdown in the absence of the previouslydiscussed signs is not considered a wound infection.Wounds are examined twice daily during hospitalization for evidence of infection. After discharge, the women are instructed on the signs and symptoms of wound infection, and asked to contact one of the co-authors immediately if any of the listed symptoms appeared. All participants are examined at 2 and 6 weeks after surgery.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 300
Est. completion date June 2019
Est. primary completion date May 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 19 Years to 37 Years
Eligibility Inclusion Criteria:

- Subjects candidate for the study will be 37 weeks' gestation

- require a cesarean section (elective or emergency).

Exclusion Criteria:

- Patients with allergy to iodine

- history of immunosuppressive drug use,

- gestationaldiabetes mellitus

- preeclampsia

- anemic patients

- ruptured of membranes

- feverish patients

Study Design


Intervention

Other:
irrigation
irrigation the edges of the cs scar before closure

Locations

Country Name City State
Egypt Kasr El Ainy Cairo

Sponsors (1)

Lead Sponsor Collaborator
Kasr El Aini Hospital

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary incidence of cs scar infection incidence of cs scar infection 2 to 6 weeks
Secondary incidence of hematoma, seroma incidence of hematoma, seroma, wound breakdown 2 to 6 weeks